In vivo responses of the primate corpus luteum to luteinizing hormone and chorionic gonadotropin.
Although it is well established that the secretory activity of the corpus luteum absolutely depends on the presence of pituitary-derived luteinizing hormone (LH), it is unknown why the life span of the corpus luteum is extended during early pregnancy by the placental production of chorionic gonadotropin (CG) but regresses in the presence of LH despite the fact that CG and LH have similar actions on the corpus luteum. To compare the responses of the corpus luteum to LH and human CG (hCG), cynomolgus monkeys whose endogenous gonadotropin secretion was blocked during the luteal phase of the menstrual cycle with a gonadotropin-releasing hormone antagonist were i.v. infused with either LH or CG. Infusion of LH at a constant rate overcame the gonadotropin-releasing hormone antagonist-mediated premature luteal regression but failed to prolong the functional life span of the corpus luteum. Continuous infusions of hCG did not effect a pregnancy-like pattern of gonadotropin secretion, but the functional life span of the corpus luteun was extended in two of three animals. Infusion of either LH or hCG in an exponentially increasing manner prolonged the functional life span of the corpus luteum beyond its normal duration. These results indicate that luteal regression at the termination of nonfertile menstrual cycles is caused by a large reduction in the responsiveness of the aging corpus luteum to LH, which can be overcome by elevated concentrations of either LH or CG.
Zeleznik
A J
AJ
Departments of Cell Biology and Physiology and Obstetrics, Gynecology and Reproductive Sciences, The University of Pittsburgh School of Medicine and the Magee-Women's Research Institute, Pittsburgh, PA 15213, USA. zeleznik+@pitt.edu
D000818:Animals; D006063:Chorionic Gonadotropin / Q000008:administration & dosage / Q000097:blood / Q000502:physiology*; D003338:Corpus Luteum / Q000502:physiology*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors; D007262:Infusions, Intravenous; D007986:Luteinizing Hormone / Q000008:administration & dosage / Q000502:physiology*; D008252:Macaca fascicularis; D008597:Menstrual Cycle; D011247:Pregnancy; D011374:Progesterone / Q000096:biosynthesis
D006063:Chorionic Gonadotropin; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D007986:Luteinizing Hormone